Lista de obras - Paul J Clark - Dominio Público Uruguay

Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer

article

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

artículo científico publicado en 2011

Bilirubin acts as a multi-potent guardian of cardiovascular integrity: more than just a radical idea.

artículo científico publicado en 2018

Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C.

artículo científico publicado en 2011

Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin

artículo científico publicado en 2015

Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response

artículo científico publicado en 2012

Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.

artículo científico publicado en 2011

Enhancing hepatitis C treatment in the custodial setting: a national roadmap.

artículo científico publicado en 2014

Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading.

artículo científico publicado en 2018

Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

artículo científico publicado en 2017

Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection

scientific article published on 29 September 2010

Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients

artículo científico publicado en 2011

Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype

artículo científico publicado en 2010

Hepatitis C virus nonstructural protein 5A inhibitors: Novel target-Now for new trials and new treatment strategies ⬇️

artículo científico publicado el 1 de septiembre de 2010

Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy.

artículo científico publicado en 2015

Host genomics and HCV treatment response.

artículo científico publicado en 2012

Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy.

artículo científico publicado en 2013

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR ⬇️

artículo científico publicado el 10 de enero de 2011

Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey

artículo científico publicado en 2018

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients ⬇️

artículo científico publicado el 1 de julio de 2011

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

artículo científico publicado en 2012

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort

Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability.

artículo científico publicado en 2016

Lost in translation? IL28B's discovery and the journey back to the patient.

artículo científico publicado en 2012

More needs to be spent on hepatitis C treatment, not less

artículo científico publicado en 2018

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C

artículo científico publicado en 2011

Noninvasive tools to assess liver disease.

artículo científico publicado en 2011

Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication

artículo científico publicado en 2014

Overcoming barriers to care for hepatitis C.

artículo científico publicado en 2012

Predictors of consent to pharmacogenomics testing in the IDEAL study.

artículo científico publicado en 2013

Projections of primary liver cancer to 2030 in 30 countries worldwide.

artículo científico

Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size.

artículo científico publicado en 2014

Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia.

artículo científico publicado en 2015

Resolution of protein-losing enteropathy after successful heart transplantation in an adult patient with arrhythmogenic right ventricular cardiomyopathy (ARVC)

artículo científico publicado en 2007

Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease.

artículo científico publicado en 2015

The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent

artículo científico publicado en 2014

The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection

artículo científico publicado en 2012

Trends in hepatitis C treatment uptake in the United States

artículo científico publicado en 2014

Use of telehealth to treat and manage chronic viral hepatitis in regional Queensland.

artículo científico publicado en 2016

Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations

scientific article published on 22 August 2018

Utility of eosinophilia as a diagnostic clue in lower abdominal pain in northern Australia: a retrospective case-control study

artículo científico publicado en 2008

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes

artículo científico publicado en 2011

Lista de obras de Paul J Clark

Association between hypermethylation of DNA repetitive elements in white blood cell DNA and pancreatic cancer

Beneficial IL28B genotype associated with lower frequency of hepatic steatosis in patients with chronic hepatitis C

Bilirubin acts as a multi-potent guardian of cardiovascular integrity: more than just a radical idea.

Characterization of serum proteins associated with IL28B genotype among patients with chronic hepatitis C.

Dysregulation of distal cholesterol biosynthesis in association with relapse and advanced disease in CHC genotype 2 and 3 treated with sofosbuvir and ribavirin

Dysregulation of innate immunity in hepatitis C virus genotype 1 IL28B-unfavorable genotype patients: impaired viral kinetics and therapeutic response

Elevated serum CK18 levels in chronic hepatitis C patients are associated with advanced fibrosis but not steatosis.

Enhancing hepatitis C treatment in the custodial setting: a national roadmap.

Evaluation of a bone morphogenetic protein 6 variant as a cause of iron loading.

Exploratory study into the unmet supportive needs of people diagnosed with cirrhosis in Queensland, Australia

Genetic variation in IL28B: impact on drug development for chronic hepatitis C infection

Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients

Hepatitis C trials that combine investigational agents with pegylated interferon should be stratified by interleukin-28B genotype

Hepatitis C virus nonstructural protein 5A inhibitors: Novel target-Now for new trials and new treatment strategies ⬇️

Hepatobiliary and Pancreatic: Acute hepatitis in the setting of chronic Schistosoma mansoni infection and post-praziquantel therapy.

Host genomics and HCV treatment response.

Inosine triphosphatase deficiency helps predict anaemia, anaemia management and response in chronic hepatitis C therapy.

Inosine triphosphatase genetic variants are protective against anemia during antiviral therapy for HCV2/3 but do not decrease dose reductions of RBV or increase SVR ⬇️

Insights into the hepatocellular carcinoma patient journey: results of the first global quality of life survey

Insulin resistance is independently associated with significant hepatic fibrosis in Asian chronic hepatitis C genotype 2 or 3 patients ⬇️

Interleukin 28B polymorphisms are the only common genetic variants associated with low-density lipoprotein cholesterol (LDL-C) in genotype-1 chronic hepatitis C and determine the association between LDL-C and treatment response.

Liver Disease and Poor Adherence Limit Hepatitis C Cure: A Real-World Australian Treatment Cohort

Liver-related mortality in countries of the developed world: an ecological study approach to explain the variability.

Lost in translation? IL28B's discovery and the journey back to the patient.

More needs to be spent on hepatitis C treatment, not less

Natural killer inhibitory receptor expression associated with treatment failure and interleukin-28B genotype in patients with chronic hepatitis C

Noninvasive tools to assess liver disease.

Osteopontin is up-regulated in chronic hepatitis C and is associated with cellular permissiveness for hepatitis C virus replication

Overcoming barriers to care for hepatitis C.

Predictors of consent to pharmacogenomics testing in the IDEAL study.

Projections of primary liver cancer to 2030 in 30 countries worldwide.

Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size.

Remoteness, race and social disadvantage: disparities in hepatocellular carcinoma incidence and survival in Queensland, Australia.

Resolution of protein-losing enteropathy after successful heart transplantation in an adult patient with arrhythmogenic right ventricular cardiomyopathy (ARVC)

Systematic review: unmet supportive care needs in people diagnosed with chronic liver disease.

The association of IL28B genotype with the histological features of chronic hepatitis C is HCV genotype dependent

The association of genetic variants with hepatic steatosis in patients with genotype 1 chronic hepatitis C infection

Trends in hepatitis C treatment uptake in the United States

Use of telehealth to treat and manage chronic viral hepatitis in regional Queensland.

Using Stepwise Pharmacogenomics and Proteomics to Predict Hepatitis C Treatment Response in Difficult to Treat Patient Populations

Utility of eosinophilia as a diagnostic clue in lower abdominal pain in northern Australia: a retrospective case-control study

Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia in HIV/HCV-coinfected patients with all HCV genotypes